Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Clinical trial NCT01363128 · COMPLETED

Trial details

NCT number: NCT01363128
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Adult Acute Lymphoblastic Leukemia in Complete Remission Burkitt Leukemia Burkitt Lymphoma CD20 Positive Childhood Acute Lymphoblastic Leukemia in Complete Remission Lymphoblastic Lymphoma

Start date: 2011-07-12
Primary completion: 2020-04-08
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.